Drug Type Monoclonal antibody |
Synonyms Rcombinant anti-CD25 chimeric antibody |
Target |
Action inhibitors |
Mechanism IL2RA inhibitors(Interleukin-2 receptor alpha chain inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingIND Application |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Graft Rejection | IND Application | China | 12 May 2005 |






